Heart Failure Reviews

Papers
(The H4-Index of Heart Failure Reviews is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome74
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program65
Trends and complications associated with acute new-onset heart failure: a National Readmissions Database–based cohort study43
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis42
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction41
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making39
Polypharmacy definition and prevalence in heart failure: a systematic review38
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 202037
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis36
Right ventricular failure: a comorbidity or a clinical emergency?35
The cardiosplenic axis: the prognostic role of the spleen in heart failure31
Can mechanical circulatory support be an effective treatment for HFpEF patients?30
Correction to: Is it time to revisit ICD indications?28
The role of TAVR in patients with heart failure: do we have the responses to all questions?28
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction28
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris28
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?26
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review25
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition25
Dependence and reduced motor function in heart failure: future directions for well-being25
Mechanisms, time course and predictability of premature ventricular contractions cardiomyopathy—an update on its development and resolution25
Advanced cardiovascular multimodal imaging and aortic stenosis24
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?24
Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers23
0.038427829742432